Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas

Biotech Teases Non-COVID Respiratory Programs

Moderna announced data from the Phase II/III KidCOVE study of Spikevax • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip